11 January 2021 | News
Sputnik V has been registered under the same procedure earlier in Argentina, Bolivia and Serbia
Source credit: Shutterstock
The Russian Direct Investment Fund (RDIF) has announced the registration of the Sputnik V vaccine against coronavirus by the National Agency of Pharmaceutical Products of People's Democratic Republic of Algeria.
The vaccine was registered under the emergency use authorisation procedure. Sputnik V has been registered under the same procedure earlier in Argentina, Bolivia and Serbia.
Supplies of the vaccine to Algeria will be facilitated by international partners of RDIF in India, China, South Korea and other countries.
Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said, “RDIF welcomes the first registration of Sputnik V vaccine in Africa. The supplies of the vaccine to Algeria will help protect the population and support the full recovery of economic activity”.